Case number 2019-1582
Boston Scientific v. Nevro Corp. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | BOSTON SCIENTIFIC v. NEVRO CORP. [OPINION] [nonprecedential] (0) |
| Jul 20, 2020 | 93 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [708447] [19-1582, 19-1635] [JAB] [Entered: 07/20/2020 10:11 AM] (0) |
| May 29, 2020 | 91 | OPINION filed for the court by Lourie, Circuit Judge; Moore, Circuit Judge and O'Malley, Circuit Judge. Nonprecedential Opinion. [697759] [19-1582, 19-1635] [JAB] [Entered: 05/29/2020 09:17 AM] (0) |
| May 29, 2020 | 92 | JUDGMENT. AFFIRMED. Terminated on the merits after submission on the briefs. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [697760] [19-1582, 19-1635] [JAB] [Entered: 05/29/2020 09:18 AM] (0) |
| May 4, 2020 | 90 | Submitted ON THE BRIEFS. Panel: Judge: Lourie , Judge: Moore , Judge: O'Malley. [691954] [JCP] [Entered: 05/04/2020 01:23 PM] (0) |
| Apr 6, 2020 | 89 | ORDER filed. The oral argument scheduled for May 4, 2020, is canceled. These appeals will be submitted on the briefs without oral argument on that date.By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [684311] [19-1582, 19-1584] [JAB] [Entered: 04/06/2020 10:51 AM] (0) |
| Mar 20, 2020 | 88 | NOTICE OF ORAL ARGUMENT. Panel: 2005C. Case scheduled May 4, 2020 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 203. Response to Notice of Oral Argument due: 04/15/2020. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [680407] [JAB] [Entered: 03/20/2020 09:47 AM] (0) |
| Feb 21, 2020 | 86 | The following conflict dates submitted by Attorney Ching-Lee Fukuda for Cross-Appellant Nevro Corp. have been accepted by the court: 05/05/2020, 05/06/2020, 06/01/2020, 06/02/2020, 06/03/2020, 06/04/2020, 06/05/2020. [673066] [JAB] [Entered: 02/21/2020 08:57 AM] (0) |
| Feb 21, 2020 | 87 | The following conflict dates submitted by Attorney Matthew Wolf for Appellant Boston Scientific Neuromodulation Corporation have been accepted by the court: 04/06/2020, 04/07/2020, 04/08/2020, 04/09/2020, 04/10/2020, 06/05/2020, 07/08/2020, 07/09/2020, 07/10/2020. [673068] [JAB] [Entered: 02/21/2020 08:59 AM] (0) |
| Feb 19, 2020 | 85 | Notice from Appellant Boston Scientific Neuromodulation Corporation regarding conflicts with oral argument. Service: 02/19/2020 by email. [672418] [19-1582] [Matthew Wolf] [Entered: 02/19/2020 01:50 PM] (0) |
| Feb 19, 2020 | 84 | Notice from Cross-Appellant Nevro Corp. regarding conflicts with oral argument. Service: 02/19/2020 by email. [672324] [19-1582] [Ching-Lee Fukuda] [Entered: 02/19/2020 11:10 AM] (0) |
| Feb 14, 2020 | 83 | 6 paper copies of the Corrected Opening Brief [23] received from Appellant Boston Scientific Neuromodulation Corporation. [671763] [JCP] [Entered: 02/17/2020 10:23 AM] (0) |
| Feb 14, 2020 | 82 | 6 paper copies of the Corrected Reply Brief [34] received from Appellant Boston Scientific Neuromodulation Corporation. [671761] [JCP] [Entered: 02/17/2020 10:22 AM] (0) |
| Feb 14, 2020 | 81 | 6 paper copies of the Corrected Confidential Joint Appendix in 2 Volumes [59] received from Appellant Boston Scientific Neuromodulation Corporation. [671760] [JCP] [Entered: 02/17/2020 10:17 AM] (0) |
| Feb 12, 2020 | 80 | 6 paper copies of the Reply Brief [35] received from Cross-Appellant Nevro Corp. [670937] [CJF] [Entered: 02/13/2020 07:33 AM] (0) |
| Feb 12, 2020 | 79 | 6 paper copies of the Corrected Opening and Response Brief [31] received from Cross-Appellant Nevro Corp. [670935] [CJF] [Entered: 02/13/2020 07:31 AM] (0) |
| Feb 12, 2020 | 78 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [670570] [JAL] [Entered: 02/12/2020 09:31 AM] (1) |
| Feb 12, 2020 | 77 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [670569] [JAL] [Entered: 02/12/2020 09:31 AM] (0) |
| Feb 10, 2020 | 76 | Letter from Intervenor Iancu Letter Re: Participation. Service: 02/10/2020 by email. [669765] [19-1582] [Mai-Trang Dang] [Entered: 02/10/2020 12:13 PM] (3) |
| Feb 5, 2020 | 75 | ORDER. Within 5 days of the date of filing of this order, the Director of the United States Patent and Trademark Office is directed to inform this court whether he intends to participate at oral argument in these appeals. Service as of this date by the Clerk of Court. [668559] [19-1582, 19-1584] [LMS] [Entered: 02/05/2020 10:40 AM] (2) |
| Jan 30, 2020 | 74 | Docketing Statement for the Intervenor Iancu. Service: 01/30/2020 by email. [667391] [19-1582] [Mai-Trang Dang] [Entered: 01/30/2020 03:21 PM] (3) |
| Jan 23, 2020 | 73 | ORDER filed denying [62] motion to reconsider order, to reconsider order en banc filed by Boston Scientific Neuromodulation Corporation in 19-1582; denying [654761-2] motion to reconsider order, to reconsider order en banc filed by Boston Scientific Neuromodulation Corporation in 19-1584. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [665337] [19-1582, 19-1584] [JAB] [Entered: 01/23/2020 08:49 AM] (3) |
| Jan 16, 2020 | 72 | ORDER filed. The Director of the United States Patent and Trademark Office is added as an intervenor. The revised official caption is reflected in the order. See order for further instructions. Service as of this date by the Clerk of Court. [663863] [JAL] [Entered: 01/16/2020 02:37 PM] (2) |
| Jan 9, 2020 | 71 | REPLY of Appellant Boston Scientific Neuromodulation Corporation to response [70], response [65]. Service: 01/09/2020 by email. [662043] [19-1582] [David Caine] [Entered: 01/09/2020 06:06 PM] (13) |
| Jan 6, 2020 | 70 | RESPONSE from Intervenor-Director of the United States Patent and Trademark Office to the motion to reconsider order [62] filed by Appellants Boston Scientific Neuromodulation Corporation and Boston Scientific Neuromodulation Corporation, motion to reconsider order en banc [62] filed by Appellants Boston Scientific Neuromodulation Corporation and Boston Scientific Neuromodulation Corporation. Service: 01/06/2020 by email. [661101] [19-1582] [Farheena Rasheed] [Entered: 01/06/2020 10:33 PM] (11) |
| Jan 6, 2020 | 69 | Entry of appearance for Farheena Y. Rasheed as of counsel for the Director of the United States Patent and Trademark Office. Service: 01/06/2020 by email. [661091] [19-1582] [Farheena Rasheed] [Entered: 01/06/2020 07:46 PM] (1) |
| Jan 6, 2020 | 68 | Entry of appearance for Thomas W. Krause as of counsel for the Director of the United States Patent and Trademark Office. Service: 01/06/2020 by email. [661089] [19-1582] [Thomas Krause] [Entered: 01/06/2020 07:43 PM] (1) |
| Jan 6, 2020 | 67 | Entry of appearance for Mai-Trang D. Dang as principal counsel for the Director of the United States Patent and Trademark Office. Service: 01/06/2020 by email. [661088] [19-1582] [Mai-Trang Dang] [Entered: 01/06/2020 07:40 PM] (1) |
| Jan 6, 2020 | 66 | Notice of Intervention pursuant to the provisions of 35 USC Section 143 from the Director of the United States Patent and Trademark Office. Service: 01/06/2020 by email. [661087] [19-1582] [Mai-Trang Dang] [Entered: 01/06/2020 07:38 PM] (3) |
| Jan 6, 2020 | 65 | RESPONSE of Cross-Appellant Nevro Corp. to the motion [62] filed by Appellants Boston Scientific Neuromodulation Corporation and Boston Scientific Neuromodulation Corporation, motion [62] filed by Appellants Boston Scientific Neuromodulation Corporation and Boston Scientific Neuromodulation Corporation. Service: 01/06/2020 by email. [660932] [19-1582] [Ching-Lee Fukuda] [Entered: 01/06/2020 02:41 PM] (14) |
| Dec 13, 2019 | 64 | ORDER granting motion to extend time to file other [63] in 19-1582, granting motion to extend time to file other [656293-2] in 19-1584. Any responses by Nevro Corp. and the United States to the motions for reconsideration [62] [654761-2] must be filed no later than January 6, 2020. Any reply in support of the motions is due no later than three days thereafter. Service as of this date by the Clerk of Court. [656458] [19-1582, 19-1584] [NL] [Entered: 12/13/2019 12:31 PM] (2) |
| Dec 12, 2019 | 63 | MOTION of Cross-Appellant Nevro Corp. to extend the time to 01/15/2020 to file Response/Reply [Consent: opposed]. Service: 12/12/2019 by email. [656297] [19-1582] [Ching-Lee Fukuda] [Entered: 12/12/2019 08:24 PM] (15) |
| Dec 6, 2019 | 62 | MODIFIED ENTRY: MOTION of Appellant Boston Scientific Neuromodulation Corporation to reconsider order [56], and to to reconsider order en banc [56] [Consent: not addressed]. Service: 12/06/2019 by email. [654760]--[Edited 12/11/2019 by JCA - Reason: to revise docket text] [David Caine] [Entered: 12/06/2019 04:59 PM] (31) |
| Dec 5, 2019 | 61 | RESPONSE of Cross-Appellant Nevro Corp. to the supplemental authority [60] filed by Appellant Boston Scientific Neuromodulation Corporation. Service: 12/05/2019 by email. [654449] [19-1582] [Ching-Lee Fukuda] [Entered: 12/05/2019 06:54 PM] (3) |
| Dec 4, 2019 | 60 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Boston Scientific Neuromodulation Corporation. Service: 12/04/2019 by email. [654146] [19-1582] [David Caine] [Entered: 12/04/2019 04:50 PM] (12) |
| Dec 3, 2019 | 59 | MODIFIED ENTRY: CORRECTED CONFIDENTIAL JOINT APPENDIX FILED for Appellant Boston Scientific Neuromodulation Corporation. Number of Pages: 713. Service: 12/03/2019 by email. [653674]--[Edited 12/05/2019 by JAL - Compliance review complete] [David Caine] [Entered: 12/03/2019 02:17 PM] (0) |
| Dec 3, 2019 | 58 | MODIFIED ENTRY: CORRECTED JOINT APPENDIX FILED for Appellant Boston Scientific Neuromodulation Corporation. Number of Pages: 664. Service: 12/03/2019 by email. [653672]--[Edited 12/05/2019 by JAL - Compliance review complete] [David Caine] [Entered: 12/03/2019 02:13 PM] (664) |
| Dec 3, 2019 | 57 | Notice of Correction to Doc No. [40], [41], [43], [44], [52], [53] for Appellant Boston Scientific Neuromodulation Corporation. Service: 12/03/2019 by email. [653669] [19-1582] [David Caine] [Entered: 12/03/2019 02:08 PM] (2) |
| Nov 22, 2019 | 56 | ORDER filed denying [45] motion leave to file supplemental brief filed by Boston Scientific Neuromodulation Corporation in 19-1582, denying [648703-2] motion leave to file supplemental brief filed by Boston Scientific Neuromodulation Corporation in 19-1584; denying [50] motion to extend time to file other filed by Nevro Corp. in 19-1582, denying [650364-2] motion to extend time to file other filed by Nevro Corp. in 19-1584; denying [47] motion to stay appeal in 19-1582, denying [650227-2] motion to stay appeal in 19-1584.. Service as of this date by the Clerk of Court. [651679] [19-1582, 19-1584] [NL] [Entered: 11/22/2019 11:35 AM] (3) |
| Nov 20, 2019 | 55 | RESPONSE of Appellant Boston Scientific Neuromodulation Corporation to the motion to stay appeal [47] , motion to extend time to file other [47]. Service: 11/20/2019 by email. [650981] [19-1582] [David Caine] [Entered: 11/20/2019 03:05 PM] (14) |
| Nov 20, 2019 | 54 | RESPONSE of Appellant Boston Scientific Neuromodulation Corporation to the motion [50] filed by Cross-Appellant Nevro Corp.. Service: 11/20/2019 by email. [650980] [19-1582] [David Caine] [Entered: 11/20/2019 03:04 PM] (9) |
| Nov 19, 2019 | 53 | MODIFIED ENTRY: CORRECTED CONFIDENTIAL JOINT APPENDIX FILED for Appellant Boston Scientific Neuromodulation Corporation. Number of Pages: 713. Service: 11/19/2019 by email. [650703]--[Edited 11/22/2019 by JAL - Compliance review complete] This brief has been corrected. See Doc No.[59] [David Caine] [Entered: 11/19/2019 05:59 PM] (0) |
| Nov 19, 2019 | 52 | MODIFIED ENTRY: CORRECTED JOINT APPENDIX FILED for Appellant Boston Scientific Neuromodulation Corporation. Number of Pages: 664. Service: 11/19/2019 by email. [650702] --[Edited 11/22/2019 by JAL - Compliance review complete] This brief has been corrected. See Doc No.[58] [David Caine] [Entered: 11/19/2019 05:55 PM] (664) |
| Nov 19, 2019 | 51 | Notice of Correction to Doc No. [44], [43] for Appellant Boston Scientific Neuromodulation Corporation. Service: 11/19/2019 by email. [650701] [19-1582] [David Caine] [Entered: 11/19/2019 05:52 PM] (2) |
| Nov 18, 2019 | 50 | MOTION of Cross-Appellant Nevro Corp. to extend the time to 12/26/2019 to file Response/Reply [Consent: opposed]. Service: 11/18/2019 by email. [650358] [19-1582] [Ching-Lee Fukuda] [Entered: 11/18/2019 07:11 PM] (13) |
| Nov 18, 2019 | 49 | Entry of appearance for Scott R. McIntosh as of counsel for United States. Service: 11/18/2019 by email. [650325] [19-1582] [Scott McIntosh] [Entered: 11/18/2019 05:00 PM] (1) |
| Nov 18, 2019 | 48 | Entry of appearance for Courtney L. Dixon as of counsel for United States. Service: 11/18/2019 by email. [650234] [19-1582] [Courtney Dixon] [Entered: 11/18/2019 03:19 PM] (1) |
| Nov 18, 2019 | 47 | MODIFIED ENTRY: MOTION of United States for stay of proceedings, or, in the alternative, extension of time to respond [Consent: partial consent]. Service: 11/18/2019 by email. [650223]--[Edited 11/19/2019 by MJL to correct relief] [Courtney Dixon] [Entered: 11/18/2019 03:12 PM] (8) |
| Nov 14, 2019 | 46 | ORDER Notice of Boston Scientific's constitutional challenge [45] [648703-2] is hereby certified to the Attorney General. The United States' request to intervene and any response by the United States and Nevro Corp. to the motions is due no later than ten days from the date of filing of this order. Any reply in support of the motions is due no later than five days thereafter. Service as of this date by the Clerk of Court. [649379] [19-1582, 19-1584] [LMS] [Entered: 11/14/2019 02:47 PM] (3) |
| Nov 12, 2019 | 45 | MOTION of Appellant Boston Scientific Neuromodulation Corporation to File Supplemental Briefs Addressing Appointments Clause [Consent: opposed]. Service: 11/12/2019 by email. [648700] [19-1582] [David Caine] [Entered: 11/12/2019 03:14 PM] (31) |
| Nov 11, 2019 | 43 | FILED from Appellant Boston Scientific Neuromodulation Corporation. Title: CORRECTED APPENDIX. Service: 11/11/2019 by email. [648415] [19-1582] This document has been corrected. See Doc No.[52]--[Edited 11/20/2019 by JAL] [David Caine] [Entered: 11/11/2019 03:03 PM] (664) |
| Nov 11, 2019 | 44 | FILED from Appellant Boston Scientific Neuromodulation Corporation. Title: CORRECTED CONFIDENTIAL APPENDIX. Service: 11/11/2019 by email. [648416] [19-1582] This document has been corrected. See Doc No.[53]--[Edited 11/20/2019 by JAL] [David Caine] [Entered: 11/11/2019 03:05 PM] (0) |
| Nov 7, 2019 | 42 | NOTICE OF NON-COMPLIANCE: The submissions of Appellant Boston Scientific Neuromodulation Corporation, Appendix and Confidential Appendix [40], [41], are not in compliance with the rules of this court (see attached). Compliant documents are due on 11/15/2019. Service as of this date by the Clerk of Court. [647803] [JAL] [Entered: 11/07/2019 02:35 PM] (2) |
| Nov 5, 2019 | 38 | Certificate of Compliance with Fed. Cir. R. 17 (Agency) for Appellant Boston Scientific Neuromodulation Corporation. Service: 11/05/2019 by email. [647141] [19-1582] [David Caine] [Entered: 11/05/2019 08:11 PM] (3) |
| Nov 5, 2019 | 41 | FILED from Appellant Boston Scientific Neuromodulation Corporation. Title: CONFIDENTIAL APPENDIX. Service: 11/05/2019 by email. [647144] [19-1582] This document is non-compliant. See Doc No.[42] [David Caine] [Entered: 11/05/2019 08:24 PM] (0) |
| Nov 5, 2019 | 40 | FILED from Appellant Boston Scientific Neuromodulation Corporation. Title: APPENDIX. Service: 11/05/2019 by email. [647143] [19-1582] This document is non-compliant. See Doc No.[42] [David Caine] [Entered: 11/05/2019 08:21 PM] (664) |
| Nov 5, 2019 | 39 | Notice from Appellant Boston Scientific Neuromodulation Corporation of Intent to File Supplemental Appendix of Video Recording on CD-ROM. Service: 11/05/2019 by email. [647142] [19-1582] [David Caine] [Entered: 11/05/2019 08:14 PM] (3) |
| Nov 5, 2019 | 37 | Certificate of Compliance with Fed. Cir. R. 17 (Agency) for Cross-Appellant Nevro Corp.. Service: 11/05/2019 by email. [647118] [19-1582] [Ching-Lee Fukuda] [Entered: 11/05/2019 05:55 PM] (3) |
| Nov 5, 2019 | 36 | Supplementary Media Appendix received on CD-ROM from Boston Scientific Neuromodulation Corporation. Number of copies: 4. [646971] [JCP] [Entered: 11/05/2019 02:46 PM] (0) |
| Oct 29, 2019 | 35 | MODIFIED ENTRY: REPLY BRIEF FILED for Cross-Appellant Nevro Corp. Number of Pages: 9. Service: 10/29/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [645632] --[Edited 10/31/2019 by JAL - Compliance review complete] [Ching-Lee Fukuda] [Entered: 10/29/2019 06:00 PM] (17) |
| Oct 10, 2019 | 34 | MODIFIED ENTRY: CORRECTED RESPONSE AND REPLY BRIEF FILED for Appellant Boston Scientific Neuromodulation Corporation. Number of Pages: 32. Service: 10/10/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of the original version of this brief [32]. See Fed. Cir. R. 31. [641685] --[Edited 10/11/2019 by JAL - Compliance review complete] [David Caine] [Entered: 10/10/2019 05:40 PM] (41) |
| Oct 9, 2019 | 33 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Boston Scientific Neuromodulation Corporation, Response and Reply Brief [32], is not in compliance with the rules of this court (see attached). Compliant document is due on 10/17/2019. The deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [641240] [JAL] [Entered: 10/09/2019 09:57 AM] (1) |
| Oct 8, 2019 | 32 | FILED from Appellant Boston Scientific Neuromodulation Corporation. Title: REPLY BRIEF. Service: 10/08/2019 by email. [641175] [19-1582] This document is non-compliant. See Doc No.[33] [David Caine] [Entered: 10/08/2019 07:02 PM] (40) |
| Aug 30, 2019 | 31 | MODIFIED ENTRY: CORRECTED OPENING AND RESPONSE BRIEF FILED for Cross-Appellant Nevro Corp. Number of Pages: 95. Service: 08/30/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of the original version of this brief [29]. See Fed. Cir. R. 31. [632381] --[Edited 09/03/2019 by JAL - Compliance review complete] [Ching-Lee Fukuda] [Entered: 08/30/2019 02:07 PM] (107) |
| Aug 30, 2019 | 30 | NOTICE OF NON-COMPLIANCE: The submission of Cross-Appellant Nevro Corp., Principal and Response Brief [29], is not in compliance with the rules of this court (see attached). Compliant document is due on 09/09/2019. The deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [632207] [JAL] [Entered: 08/30/2019 09:49 AM] (1) |
| Aug 29, 2019 | 29 | FILED from Cross-Appellant Nevro Corp.. Title: RESPONSE BRIEF. Service: 08/29/2019 by email. [632107] [19-1582] This document is non-compliant. See Doc No.[30] [Ching-Lee Fukuda] [Entered: 08/29/2019 05:11 PM] (106) |
| Aug 6, 2019 | 28 | Certificate of Interest for Cross-Appellant Nevro Corp.. Service: 08/06/2019 by email. [626471] [19-1582] [Ching-Lee Fukuda] [Entered: 08/06/2019 05:21 PM] (3) |
| Jul 2, 2019 | 27 | ORDER filed. The motions [24] [616892-2] are granted. Service: 07/02/2019 by clerk. [618581] [19-1582, 19-1584] [LMS] [Entered: 07/02/2019 01:44 PM] (2) |
| Jun 26, 2019 | 26 | REPLY of Cross-Appellant Nevro Corp. to response [25]. Service: 06/26/2019 by email. [617196] [19-1582] [Ching-Lee Fukuda] [Entered: 06/26/2019 04:28 PM] (6) |
| Jun 25, 2019 | 25 | RESPONSE of Appellant Boston Scientific Neuromodulation Corporation to the motion to extend time to file brief [24] filed by Cross-Appellant Nevro Corp.. Service: 06/25/2019 by email. [616946] [19-1582] [David Caine] [Entered: 06/25/2019 11:34 PM] (11) |
| Jun 25, 2019 | 24 | MOTION of Cross-Appellant Nevro Corp. to extend the time to 08/29/2019 to file the PRINCIPAL AND RESPONSE BRIEF. [Consent: opposed]. Service: 06/25/2019 by email. [616907] [19-1582] [Ching-Lee Fukuda] [Entered: 06/25/2019 04:47 PM] (10) |
| Jun 4, 2019 | 23 | MODIFIED ENTRY: CORRECTED OPENING BRIEF FILED for Appellant Boston Scientific Neuromodulation Corporation. Number of Pages: 66. Service: 06/04/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of the original version of this brief [21]. See Fed. Cir. R. 31. [611326] --[Edited 06/04/2019 by JAL - Compliance review complete] [David Caine] [Entered: 06/04/2019 12:52 PM] (296) |
| Jun 4, 2019 | 22 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Boston Scientific Neuromodulation Corporation, Opening Brief [21], is not in compliance with the rules of this court (see attached). Compliant document is due on 06/11/2019. Service as of this date by the Clerk of Court.[611275] [JAL] [Entered: 06/04/2019 11:05 AM] (2) |
| Jun 3, 2019 | 21 | FILED from Appellant Boston Scientific Neuromodulation Corporation. Title: OPENING BRIEF. Service: 06/03/2019 by email. [611152] [19-1582] This document is non-compliant. See Doc No.[22] [David Caine] [Entered: 06/03/2019 09:47 PM] (297) |
| Jun 3, 2019 | 20 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: attorney entry of appearance Docket No. [19], ERROR: The entry of appearance for A. Tutt [19] did not list all member cases and cross-appeals of the consolidated group. CORRECTION: For future filings, please list all case numbers on the document. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [611045] [JAL] [Entered: 06/03/2019 03:08 PM] (0) |
| May 31, 2019 | 19 | Entry of appearance for Andrew Tutt as of counsel for Appellant Boston Scientific Neuromodulation Corporation. Service: 05/31/2019 by email. [610805] [19-1582] [Andrew Tutt] [Entered: 05/31/2019 04:26 PM] (2) |
| May 14, 2019 | 18 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [607169] [JAL] [Entered: 05/14/2019 12:54 PM] (0) |
| Apr 10, 2019 | 17 | Entry of appearance for Ryan C. Morris as of counsel for Cross-Appellant Nevro Corp.. Service: 04/10/2019 by email. [599134] [19-1582] [Ryan Morris] [Entered: 04/10/2019 07:17 PM] (2) |
| Apr 3, 2019 | 16 | Certified list from the United States Patent and Trademark Office. Service: 04/03/2019 by email. Appellant's brief is due 06/03/2019. [597565] [JAL] [Entered: 04/03/2019 01:01 PM] (160) |
| Mar 12, 2019 | 15 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [11], attorney entry of appearance Docket No. [14], ERROR: The entries of appearance for M. Wolf [14] and D. Caine [11] listed only the lead appeal case number of a consolidated group. CORRECTION: For future filings, please include the lead appeal case number along with any consolidated or cross-appeal case numbers. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [592147] [JAL] [Entered: 03/12/2019 11:39 AM] (0) |
| Mar 11, 2019 | 14 | Entry of appearance for Matthew M. Wolf as principal counsel for Appellant Boston Scientific Neuromodulation Corporation. Service: 03/11/2019 by email. [591972] [19-1582] [Matthew Wolf] [Entered: 03/11/2019 04:02 PM] (2) |
| Mar 11, 2019 | 13 | Docketing Statement for the Appellant Boston Scientific Neuromodulation Corporation. Service: 03/11/2019 by email. [591953] [19-1582] [David Caine] [Entered: 03/11/2019 03:45 PM] (3) |
| Mar 11, 2019 | 12 | Certificate of Interest for the Appellant Boston Scientific Neuromodulation Corporation. Service: 03/11/2019 by email. [591951] [19-1582] [David Caine] [Entered: 03/11/2019 03:44 PM] (3) |
| Mar 11, 2019 | 11 | Entry of appearance for David A. Caine as of counsel for Appellant Boston Scientific Neuromodulation Corporation. Service: 03/11/2019 by email. [591947] [19-1582] [David Caine] [Entered: 03/11/2019 03:41 PM] (2) |
| Mar 11, 2019 | 10 | Official caption revised to reflect cross-appeal 19-1635. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by the Clerk of Court. [591799] [JAL] [Entered: 03/11/2019 11:26 AM] (0) |
| Mar 11, 2019 | 9 | Note to file: The following cases are associated: 19-1582 Lead with 19-1635 Cross-Appeal. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [591798] [19-1582, 19-1635] [JAL] [Entered: 03/11/2019 11:25 AM] (0) |
| Mar 8, 2019 | 8 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [7], attorney entry of appearance Docket No. [6], docketing statement Docket No. [4], attorney entry of appearance Docket No. [3], ERROR: The filings incorrectly listed the party designation for Nevro Corp. as Appellee and Cross-Appellant. CORRECTION: For future filings, please use the party designation in the court-specified caption for Nevro Corp. in this case, which is Appellee. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [591562] [JAL] [Entered: 03/08/2019 02:55 PM] (0) |
| Mar 8, 2019 | 7 | Entry of appearance for Sharon Lee as of counsel for Appellee Nevro Corp.. Service: 03/08/2019 by email. [591553] [19-1582] [Ching-Lee Fukuda] [Entered: 03/08/2019 02:43 PM] (2) |
| Mar 8, 2019 | 6 | Entry of appearance for Jon E. Wright as of counsel for Appellee Nevro Corp.. Service: 03/08/2019 by email. [591552] [19-1582] [Ching-Lee Fukuda] [Entered: 03/08/2019 02:42 PM] (2) |
| Mar 8, 2019 | 5 | Certificate of Interest for the Appellee Nevro Corp.. Service: 03/08/2019 by email. [591546] [19-1582] [Ching-Lee Fukuda] [Entered: 03/08/2019 02:39 PM] (3) |
| Mar 8, 2019 | 4 | Docketing Statement for the Appellee Nevro Corp.. Service: 03/08/2019 by email. [591544] [19-1582] [Ching-Lee Fukuda] [Entered: 03/08/2019 02:34 PM] (4) |
| Mar 8, 2019 | 3 | Entry of appearance for Ching-Lee Fukuda as principal counsel for Appellee Nevro Corp.. Service: 03/08/2019 by email. [591542] [19-1582] [Ching-Lee Fukuda] [Entered: 03/08/2019 02:33 PM] (2) |
| Mar 4, 2019 | 2 | Note to file: 19-1584 (COMPANION started 03/04/2019) with 19-1582. These cases shall be considered companion cases and assigned to the same merits panel for oral argument. [589942] [19-1582, 19-1584] [JAL] [Entered: 03/04/2019 09:33 AM] (0) |
| Feb 25, 2019 | 1 | Appeal docketed. Received: 02/22/2019. [588248] Entry of Appearance due 03/11/2019. Certificate of Interest is due on 03/11/2019. Docketing Statement due 03/11/2019. Certified List due on 04/08/2019. [JAL] [Entered: 02/25/2019 08:49 AM] (162) |
